Acutane: Common spelling variant of Accutane (Isotretinoin) for severe acne
Acutane is a common spelling variant of the US brand name Accutane, the former original preparation of the active ingredient isotretinoin. Both terms refer to the same medication. Accutane was developed by Roche and approved in the United States in 1982; in Germany, the original preparation was marketed under the name Roaccutan. Roaccutan has largely disappeared from the German market, but generic isotretinoin preparations (Aknenormin, Isogalen, Isotretinoin Hexal, Acnatac topical) remain available.
Isotretinoin is the most effective medication for severe acne and the only one that can permanently cure the disease in many cases. It acts on all four pathogenic factors of acne (sebum production, follicular hyperkeratosis, Propionibacterium acnes, inflammation). Due to its potent efficacy, but also significant safety and teratogenic risk, isotretinoin is approved only for severe therapy-resistant acne and under strict medical supervision. A detailed pillar page can be found at /wirkstoff/isotretinoin.
Mechanism of action
Isotretinoin is the 13 cis form of retinoic acid (vitamin A acid) and exerts its effects through binding to nuclear retinoid receptors (RAR and RXR), which regulate gene expression in sebaceous and skin cells. The result is a drastic reduction in sebaceous gland activity (up to 90 percent), normalization of follicular keratinization, indirect reduction of Propionibacterium acnes (through a dry environment and reduced sebum), and anti-inflammatory effects.
This pleiotropic action explains its high efficacy but also its broad side effect spectrum. Effects on sebaceous glands are partially reversible; however, many patients experience sustained remissions or significant improvement even after treatment ends.
Pharmacokinetically, isotretinoin is better absorbed orally with a fat-rich meal (approximately double bioavailability). The substance is metabolized via CYP3A4, with a half-life of 10 to 20 hours; active metabolites prolong the effect. The substance accumulates in adipose tissue and is eliminated over weeks to months after treatment ends.
Indications
- Severe therapy-resistant acne (Acne conglobata, Acne fulminans): primary indication
- Moderate acne with failure of other therapies: after at least 3 months of conventional systemic treatment (antibiotics, hormone therapy, topical retinoids)
- Acne with scarring tendency: when at risk for permanent acne scars
- Rosacea: off-label, at low dose
- Hidradenitis suppurativa: off-label
- Certain lymphomas and leukemias: in oncologic indication, different regimens
Dosage and administration
Standard dose: 0.5 to 1 mg/kg body weight daily, divided into one to two doses, preferably with meals. Cumulative total dose 120 to 150 mg/kg over the entire course of therapy, which for a 70 kg person means approximately 4 to 6 months of treatment.
Low-dose regimens: 0.1 to 0.3 mg/kg over a longer period, with better tolerability but slower effect. In rosacea, often lower doses are used.
Administration: with a fat-rich meal, as this doubles bioavailability. Maintain intervals between daily doses.
Pregnancy prevention: mandatory in Germany according to the EMA Pregnancy Prevention Programme with information sheet, pregnancy tests before, during, and 5 weeks after therapy, reliable contraception methods throughout the period.
Side effects
Very common: Dry skin, cheilitis (chapped lips), dry eyes with conjunctivitis, dry mucous membranes (nose with nosebleeds, vagina), dry scalp with hair loss, photosensitivity, musculoskeletal complaints (myalgia, arthralgia), hyperlipidemia, elevation of liver transaminases.
Serious: Teratogenicity (extremely high risk of severe birth defects if pregnancy occurs during therapy); psychiatric effects including depression, suicidal ideation, and in individual cases suicide (causality disputed, but FDA and EMA require appropriate information); worsening of chronic inflammatory bowel disease; pancreatitis from severe hyperlipidemia; benign intracranial hypertension (pseudotumor cerebri), particularly in combination with tetracyclines; severe skin diseases such as Stevens-Johnson Syndrome and erythema multiforme.
Important: Any pregnancy during isotretinoin therapy is an emergency situation because up to 30 percent of fetuses develop the most severe birth defects. Strict adherence to the Pregnancy Prevention Programme is non-negotiable.
Drug interactions
- Tetracyclines (Doxycycline, Minocycline): additive risk of pseudotumor cerebri, combination contraindicated
- Vitamin A supplements: additive hypervitaminosis A, contraindicated
- Systemic glucocorticoids: additive hyperglycemia, hyperlipidemia
- Methotrexate: additive hepatotoxicity
- Hormonal contraceptives (oral contraceptives): possibly reduced efficacy, therefore two contraceptive methods recommended
- Alcohol: additive hepatotoxicity and hyperlipidemia
Special precautions
Pregnancy: absolutely contraindicated. Women of childbearing age must fully comply with the Pregnancy Prevention Programme, which includes: information, pregnancy test before each prescription, reliable contraception throughout therapy and 1 month after, monthly medical check-ups.
Breastfeeding: contraindicated.
Before starting therapy: Liver transaminases, lipid status (cholesterol, triglycerides), pregnancy test. Information for the patient and relatives about risks, especially teratogenicity and psychiatric effects.
Monitoring: Liver transaminases and lipid status monthly, pregnancy test monthly. Observation of psychiatric symptoms, patient and family should report changes.
Sun protection: photoprotection with SPF 30 or higher, as isotretinoin increases UV sensitivity.
Prescription requirement: Isotretinoin may only be prescribed in Germany by dermatologists or experienced general practitioners, with special prescribing requirements according to the Pregnancy Prevention Programme.
You might also be interested in
- Isotretinoin, detailed pillar page (correct active ingredient name)
- Adapalene, topical retinoid for moderate acne
- Azelaic acid, further topical acne therapy
- Clindamycin, antibiotic for acne
- Cyproterone acetate, hormonal acne therapy
Frequently asked questions
What is the difference between Acutane and Accutane?
Acutane is a common spelling variant of Accutane, both refer to the same active ingredient isotretinoin. Accutane was the original brand name from Roche in the United States; in Germany it was Roaccutan. Both have largely been replaced by generic isotretinoin preparations today.
Can isotretinoin really cure my acne?
In many patients, complete therapy with a cumulative dose of 120 to 150 mg/kg leads to sustained remission of acne even after treatment ends. Approximately 70 to 80 percent experience long-term improvement, and some require a second course after several years.
Why is pregnancy prevention so important?
Isotretinoin is one of the most teratogenic approved medications. If pregnancy occurs during therapy, up to 30 percent of fetuses develop the most severe birth defects (craniofacial, cardiac, CNS, thymus). Therefore, strict adherence to the Pregnancy Prevention Programme with two reliable contraceptive methods, monthly pregnancy tests, and physician counseling is mandatory.
What about the discussion regarding depression and suicidality?
There are reports of depressive mood and in individual cases suicide under isotretinoin. Causal relationship is disputed, particularly because acne itself can trigger depressive symptoms. Nevertheless, the FDA and EMA require appropriate information and monitoring. Patients and relatives should watch for mood changes and inform the treating practice in case of doubt.
Sources
- EMA Pregnancy Prevention Programme for Isotretinoin
- AWMF S2k guideline Treatment of acne
- Gelbe Liste, Isotretinoin active ingredient profile
- BfArM, Federal Institute for Drugs and Medical Devices
Legal notice and disclaimer
The information provided on this page is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. It does not replace the advice of a licensed physician or pharmacist. Medications should always be taken only according to a physician's prescription or appropriate pharmacy dispensing. All information is based on expert information published at the time of creation and recognized scientific sources; the current package insert of the manufacturer is always definitive. Sanoliste assumes no liability for completeness, currency, or accuracy of the information presented. In a medical emergency, call the emergency number 112.